You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › September › 17
CNBC
9 months ago
CNBC's Jim Cramer suggested major market themes haven't really changed in the wake of the Fed's meeting.
Jim Cramer says Eli Lilly's obesity pill could be more of a 'lifetime drug' than shots ○
"Persistence is the enemy of these [GLP-1 drugs] right now," CNBC's Jim Cramer said Wednesday.
Stocks like Rocket Mortgage could see the biggest gains as Fed drives down short-term rates ○
CNBC Pro screened U.S. stocks to find those with the highest inverse correlation with the two-year Treasury yield over the past 10 years.
Tim Cook says he is 'really pleased' with progress on stitching together Apple's end-to-end silicon supply chain in the U.S. ○
found
In an interview with CNBC's Jim Cramer, Apple CEO Tim Cook struck an optimistic tone about the iPhone maker's progress bringing more manufacturing to the U.S.
CNBC Daily Open: The financial world holds its breath for the Fed meeting ○
A 25 basis point cut is almost certain. A 50 point slash is unlikely, unless the "outies" of some Fed officials overpower their independent "innies."
CNBC's UK Exchange newsletter: Can UK trade come up Trumps? ○
"Tiara diplomacy" is nothing new, but with the U.K. economy stagnating, it feels like a lot is riding on President Donald Trump's visit to Britain.
The UK's top fintech companies: 2025 ○
CNBC and Statista have identified the top 150 fintechs in the U.K, within London and beyond.
CNBC's The China Connection newsletter: China’s attempt to pivot away from the U.S. starts with this trading hub ○
There's little sign that Yiwu merchants will find it attractive to sell to the U.S. again soon.
CNBC Daily Open: Nearly everything slows down the day before the Fed meeting ○
A 25 basis point cut is almost certain. A 50 point slash is unlikely, unless the "outies" of some Fed officials overpower their independent "innies."
page 1 of 1